PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Cao, JingPing ^a,b   Zhu, Shu ^a   Zhou, Wei ^a   Li, Jie ^b   Liu, Chang ^a   Xuan, HanQing ^c   Yan, Jie ^d   Zheng, Lin ^d   Zhou, LiXin ^c   Yu, JianXiu ^d   Chen, GuoQiang ^a,b   Huang, YiRan ^c   Yu, Zhuo ^a   Feng, LiXin ^a,e  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROMYELOCYTIC LEUKEMIA ZINC FINGER; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; PTEN PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; ZBTB16 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLZF GENE; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PROMOTER REGION; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, NUDE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84892164556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077922     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Yoshimoto M, Ding K, Sweet JM, Ludkovski O, Trottier G, et al. (2013) PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade. Mod Pathol 26: 435-447.
3. Hollander MC, Blumenthal GM, Dennis PA (2011) PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 11: 289-301.
4. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, et al. (2009) Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 41: 619-624.
5. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, et al. (2012) Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 72: 1878-1889.
6. Hubner A, Mulholland DJ, Standen CL, Karasarides M, Cavanagh-Kyros J, et al. (2012) JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. Proc Natl Acad Sci U S A 109: 12046-12051.
7. Chalhoub N, Baker SJ (2009) PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-150.
8. Hemmings BA, Restuccia DF (2012) PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 4: a011189.
9. Kuijk EW, van Mil A, Brinkhof B, Penning LC, Colenbrander B, et al. (2010) PTEN and TRP53 independently suppress Nanog expression in spermatogonial stem cells. Stem Cells Dev 19: 979-988.
10. Hobbs RM, Seandel M, Falciatori I, Rafii S, Pandolfi PP (2010) Plzf regulates germline progenitor self-renewal by opposing mTORC1. Cell 142: 468-479.
11. Calnan DR, Brunet A (2008) The FoxO code. Oncogene 27: 2276-2288. (Pubitemid 351501779)
12. Dansen TB, Burgering BM (2008) Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol 18: 421-429.
13. Lynch RL, Konicek BW, McNulty AM, Hanna KR, Lewis JE, et al. (2005) The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol Cancer Res 3: 163-169. (Pubitemid 40524899)
14. Zhao Y, Wang Y, Zhu WG (2011) Applications of post-translational modifications of FoxO family proteins in biological functions. J Mol Cell Biol 3: 276-282.
15. Bismar TA, Yoshimoto M, Vollmer RT, Duan Q, Firszt M, et al. (2011) PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer. BJU Int 107: 477-485.
16. Zafarana G, Ishkanian AS, Malloff CA, Locke JA, Sykes J, et al. (2012) Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer 118: 4053-4062.
17. Li Y, Su J, DingZhang X, Zhang J, Yoshimoto M, et al. (2011) PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome. J Pathol 224: 90-100.
18. Yoshimoto M, Cutz JC, Nuin PA, Joshua AM, Bayani J, et al. (2006) Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet Cytogenet 169: 128-137. (Pubitemid 44287105)
19. Cheung M, Pei J, Pei Y, Jhanwar SC, Pass HI, et al. (2010) The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene 29: 1633-1640.
20. Kikugawa T, Kinugasa Y, Shiraishi K, Nanba D, Nakashiro K, et al. (2006) PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Prostate 66: 1092-1099. (Pubitemid 43939214)
21. Suliman BA, Xu D, Williams BR (2012) The promyelocytic leukemia zinc finger protein: two decades of molecular oncology. Front Oncol 2: 74.
22. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, et al. (1999) Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18: 925-934. (Pubitemid 29086269)
23. McConnell MJ, Chevallier N, Berkofsky-Fessler W, Giltnane JM, Malani RB, et al. (2003) Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell Biol 23: 9375-9388. (Pubitemid 37499823)
24. Filipponi D, Hobbs RM, Ottolenghi S, Rossi P, Jannini EA, et al. (2007) Repression of kit expression by Plzf in germ cells. Mol Cell Biol 27: 6770-6781. (Pubitemid 47483628)
25. Zhang T, Xiong H, Kan LX, Zhang CK, Jiao XF, et al. (1999) Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene. Proc Natl Acad Sci U S A 96: 11422-11427. (Pubitemid 29487396)
26. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868. (Pubitemid 29165088)
27. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, et al. (1993) Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12: 1161-1167. (Pubitemid 23095865)
28. Barna M, Hawe N, Niswander L, Pandolfi PP (2000) Plzf regulates limb and axial skeletal patterning. Nat Genet 25: 166-172. (Pubitemid 30394986)
29. Ikeda R, Yoshida K, Tsukahara S, Sakamoto Y, Tanaka H, et al. (2005) The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1. J Biol Chem 280: 8523-8530. (Pubitemid 40349757)
30. Buaas FW, Kirsh AL, Sharma M, McLean DJ, Morris JL, et al. (2004) Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet 36: 647-652. (Pubitemid 38715995)
31. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, et al. (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68: 2745-2754. (Pubitemid 351556272)
32. Guidez F, Howell L, Isalan M, Cebrat M, Alani RM, et al. (2005) Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol Cell Biol 25: 5552-5566. (Pubitemid 40853590)
33. Amin MB (2004) Gleason grading of prostate cancer : a contemporary approach. Philadelphia, USA: Lippincott Williams & Wilkins. xi, 116 p. p.